The board of directors of Essex Bio-Technology Limited announced that Ngiam Hian Leng Malcolm and Ms. Yau Lai Man will be appointed as executive directors of the Company with effect from 19 September 2020. Ms. Yau will also be appointed as a member of the corporate governance committee on the same date. Mr. Ngiam Hian Leng Malcom, aged 36, joined the Group in 2015 and has been appointed as the deputy managing director of the Company and the president of Essex Bio-Investment Limited, a wholly- owned subsidiary of the Company, in 2018. He is also a director of Essex Bio-Pharmacy Limited, Zhuhai Essex Bio-Pharmaceutical Company Limited and Majeton Pte. Ltd., all being wholly-owned subsidiaries of the Company. Ms. Yau Lai Man, aged 57, joined the Group as the financial controller, company secretary and authorised representative of the Company since 2001. Ms. Yau is currently a director of Essex Bio- Pharmacy Limited, Zhuhai Essex Bio-Pharmaceutical Company Limited, Zhuhai Essex Technology Development Company Limited and UNO Medical (Zhuhai) Company Limited, all being wholly-owned subsidiaries of the Company.